| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |